Mountain Plains ATTC

Mental Health Professionals, in general, suffer a critical deficiency in pharmacology knowledge, which impedes their ability to evaluate their patient/clients’ needs and outcomes. An advanced degree in Clinical Psychopharmacology can equip clinicians to better meet the needs of people living with co-occurring disorders (e.g., SUD and other mental health disorders). For example, an understanding of biomedical models, disease pathology, and basic pharmacology can improve clinicians’ diagnostic skills and capacity to offer enhanced patient education related to psychotropic medication, ultimately improving patient outcomes. This presentation will highlight opportunities to pursue continuing education in this arena. Learning Objectives: List at least 3 Master of Science in Clinical Psychopharmacology (MSCP) degree requirements Name 7 postdoctoral MSCP degree programs Understand the intersectionality between American Psychological Association (APA) Designation criteria, Academic degree requirements, and State laws with prescriptive authority Regarding the field of addictions, conclude with at least 3 benefits of the training and education in Clinical Psychopharmacology for Mental Health Professionals Understand how the power to prescribe includes also the power to “unprescribe.” Dr. Casey McDougall is the Training Director and Academic Advisor for the postdoctoral M.S. Program in Clinical Psychopharmacology. This Program is only one of six APA Designated programs in the nation. Dr. Casey McDougall is a licensed clinical psychologist and prescribing medical psychologist in New Mexico. He earned his Doctorate in Clinical Psychology from the University of North Dakota and Postdoctoral Masters in Clinical Psychopharmacology from Alliant International University. He completed his Pre-Doctoral Internship through the UNM Health Sciences Center; followed by his Post-Doctoral training with the Pueblo of Acoma. He is now the fulltime Training Director for the RXPP Program and Full Professor within the CEP Dept. Moreover, he is a Consultant for the Rehabilitation Hospital for Southern New Mexico here in Las Cruces, NM. Previously he worked for Indian Health Service as the Behavioral Health Director at the Red Lake Hospital (Red Lake Nation; Red Lake, MN). He is a Veteran of Operation Iraqi Freedom III and Direct Descendant of the White Earth (Nation) Band of Chippewa where his father is enrolled. He enjoys spectator sports, outdoor activities, cooking, and off-roading. This webinar is offered in collaboration between NMSU and the SAMHSA-funded Mountain Plains ATTC. 1.5 APA sponsored CE's will be available.

A common approach in learning any complex skill is to work with experts assisting in the development of competencies. Motivational Interviewing (MI) On-the-Spot offers an opportunity to enhance practitioners’ skills and confidence in the utilization and integration of MI into practice by providing access to subject matter experts to obtain immediate feedback during a one-hour, online, open forum. Bring your questions and join in on the dialogue to increase MI knowledge and change clinical practice approaches through the utilization of an MI style of communication.   To join Motivational Interviewing OtS use the Zoom login below on the scheduled time and day: Step 1: Join from PC, Mac, Linux, iOS or Android: https://us06web.zoom.us/j/84298416541 Step 2: Join by Telephone (ONLY if device doesn't have a microphone built in): Phone: +1 669 900 6833 (US Toll) or +1 408 638 0968 (US Toll) Meeting ID: 842 9841 6541

Kratom (Mitragyna speciosa) products have gained both scientific and public interest in the US with increased reports of both adverse outcomes as well as potential deaths linked to its use. The scientific literature has reported on potential benefits of kratom as a harm reduction tool for opioid and stimulant use disorders but also reports on the limitations of its benefits by causing dependence, sometimes described as kratom use disorder. This talk is intended to describe the current state of scientific and clinical knowledge to inform healthcare and social work professionals. Objectives: Translate the complex pharmacology of kratom into clinical presentation, uses of kratom, and adverse effects. Identify the signs and symptoms associated with “kratom use disorder”. Apply the scientific and clinical knowledge about kratom to inform your counseling of patients and other healthcare professionals. Characterize the limitations of kratom use in regard to dose, frequency, and particular kratom products. Bio: Oliver Grundmann is a clinical professor at the College of Pharmacy and holds a courtesy appointment with the College of Nursing, University of Florida. He received his BPharm from the University of Münster, Germany before receiving his PhD in Pharmaceutical Sciences from the University of Florida. His research focuses on natural products and complementary and alternative medicines. He serves as section editor of the journal Current Addiction Reports, is the incoming president-elect of the American College of Clinical Pharmacology, and is working with various academic collaborators on the use and clinical impact of dietary supplements.

This webinar will address and review the latest guidance regarding ethics including ethical responsibility, rural issues related to ethics, South Dakota-specific ethics issues, core values related to ethical practice, ethical decision making models, and context related to therapy and approaches related to ethical practice.

Addiction and mental health professionals, medical providers, and recovery support staff are increasingly likely to encounter refugees and others who have experienced forced displacement. This webinar will describe the types of crises that create forced displacement, the experience of the person who was displaced, and appropriate approaches for the professional who serves those who have experienced forced displacement.

This is a recording of the webinar presented on June 26, 2024 with Sarah Rowan, MD, and Hermione Hurley, MD. The webinar focused on the advances in the treatment of hepatitis C and the impact of the current medications available for the treatment of the disease. Download Slide Deck